All In MedTech

Device Trial Radar · NCT07485244

EEG Abnormalities in Adult ICU Patients With High Risk of Delirium

Last checked: Nov 19, 2026Latest source record: Apr 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

100

Planned (sponsor's estimate)

Start

Apr 16, 2026

Primary completion

Dec 31, 2026

Study completion Sep 30, 2027

Sponsor

Lead sponsor
Ceribell Inc.Not on our public-company list
Sponsor type
Industry
Collaborators
Vanderbilt University Medical Center
First posted
Mar 20, 2026

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to assess the prevalence of EEG abnormalities on Ceribell POC EEG in adult medical, surgical, and cardiovascular ICU patients with high risk of delirium

Conditions

  • Delirium in the Intensive Care Unit

Interventions

  • Ceribell EEG SystemDevice

    EEG will be recorded with the Ceribell EEG System, including headband and recorder.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Prevalence of EEG Abnormalities on the Ceribell EEG SystemTime frame: Starting baseline through study completion, up to 1 year.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Vanderbilt University Medical Center

    Nashville, Tennessee · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.